Moffitt Cancer Center - Magnolia Campus — Tampa, Florida

Moffitt Cancer Center - Magnolia Campus is a clinical research site located in Tampa, Florida, United States 33612.

Crixeo Health Trust Score: 55/100 (POOR). This profile has not yet been claimed by the site owner.

Moffitt Cancer Center - Magnolia Campus has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Advanced Non-small Cell Lung Cancer, HER2 Mutation, Non Small Cell Lung Cancer.

Sponsors: Bayer, Genprex, Inc..

Sponsor Feasibility Report

Trust Score: 55/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Moffitt Cancer Center - Magnolia Campus?

Moffitt Cancer Center - Magnolia Campus has a Crixeo Trust Score of 55/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Moffitt Cancer Center - Magnolia Campus conducted?

Moffitt Cancer Center - Magnolia Campus has 2 clinical trials on record, with 1 currently active. Their work covers Advanced Non-small Cell Lung Cancer, HER2 Mutation, Non Small Cell Lung Cancer.

Is Moffitt Cancer Center - Magnolia Campus accredited by Crixeo Health?

Moffitt Cancer Center - Magnolia Campus has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Moffitt Cancer Center - Magnolia Campus?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.